Medical Product Archive

Pritzker | Olsen, P.A. is currently representing people injured by defective medical products and families of people whose deaths have been associated with defective products. Our experience includes litigating pharmaceutical cases, medical device cases, and a recent case involving a medication that was compounded by a pharmacy into a form that was 8 times the stated dosage.

Recalls of Unsafe Medical Devices and Prescription Medications (Drugs)
Below is a list of some products that manufacturers have recalled or modified due to defect, improper notification of risk, and/or post-marketing reports of injury and death. Most of these medications and medical devices have been the subject of Food and Drug Administration (FDA) Class I recalls, the FDA’s recall level that indicates products have the potential to cause terrible injuries, significant pain and even death.

MORE PRODUCTS:

Pseudomonas aeruginosa: DermaFreeze365™ Instant Line Relaxing Formula

March 23, 2007 - Woodridge Labs, Inc., has voluntarily recalled all lots of its DermaFreeze365™ Instant Line Relaxing Formula (UPC Codes 6-05923-36501-6, 6-05923-36502-3 and 6-05923-10563-6) and DermaFreeze365™ Neck & Chest (UPC Code 6-05923-36503-0) products. This recall was a result of certain limited lots testing positive for the Pseudomonas aeruginosa bacteria. Learn more about the recall of DermaFreeze365.

Withdrawal of Equate and Member's Mark Wet Wipes
November 17, 2006 -- Rockline Industries announced that it has initiated a voluntary nationwide product withdrawal to the retail level of certain lots of its store brand wet wipes—Equate and Member’s Mark wet wipes sold at Wal-Mart and Sam’s Club. The voluntary withdrawal is a result of routine product testing that detected the presence of a micro-organism known as Burkholderia cepacia (B. cepacia). Learn more about the recall of Equate and Member's Mark wet wipes due to Burkholderia cepacia.

Donor Referral Services
The FDA has notified the health-care community that human tissue recovered by Donor Referral Services (DRS) may not have met FDA requirements for donor eligibility. Donor eligibility is determined through donor screening and donor testing. A donor is determined eligible to donate tissues only if the results of donor screening and donor testing indicate freedom from communicable diseases or communicable disease risks. Learn more about Donor Referral Services.

Alaris® SE Pumps (formerly the Signature Edition Infusion Pumps)
Alaris® SE Pumps (formerly the Signature Edition Infusion Pumps) may cause serious harm or death. According to Cardinal Health, owner of Alaris Products, a “key bounce” in the Alaris infusion pumps may cause over-infusion of medications, possibly 10 times the amount intended. Upon the request of the FDA, the United States Marshall has seized defective Alaris infusion pumps. Learn more about Alaris SE infusion pumps.

Recall of One Lot of Azathioprine
Roxane Laboratories, Inc., has announced a recall of a single manufacturing lot of Azathioprine tablets, USP 50 mg, (NDC 00054-4084-25, Lot 558470A, Exp Mar 2009). It was discovered that a single bottle of Azathioprine tablets from lot 558470A contained Methotrexate tablets USP 2.5 mg. Learn more about the Azathioprine recall.

Disetronic D-TRONplus Power Pack Recall
Disetronic Medical Systems Inc. (Disetronic) of Fishers, IN announced today a voluntary nationwide recall of the Disetronic D-TRONplus Power Packs, that power the D-TRONplus Insulin Pump. There is the real potential that the power pack could shut down the D-TRONplus Insulin Pump without any warning. If a shut down occurs, insulin delivery is interrupted. An interruption in insulin delivery may lead to uncontrolled diabetes mellitus, resulting in hyperglycemia, which may lead to serious patient injury and/or death. Learn more about the Disetronic D-TRONplus Power Pack recall.

PIC50 External Monitor/Defibrillator
On July 7, 2006, the FDA announced the recall of 1,184 PIC50 External Monitor/Defibrillators manufactured in Buffalo Grove, Illinois between February 2002 and October of 2004 by MRL, Inc. a Welch Allyn Company. The recalled PIC50 monitor/defibrillators may display a DEFIB COMM ERROR, which may prevent or delay the delivery of therapy, which may fail to resuscitate the patient. Learn more about the PIC50 External Monitor/Defibrillator recall.

Triaminic Vapor Patch Recall
On June 19, 2006, the FDA announced the recall of Triaminic Vapor Patch products. According to the manufacturer, Novartis Consumer Health, serious adverse health effects, including seizures, could result if a Triaminic Vapor Patch is swallowed by a child who has removed the patch to chew on it. Learn more about the Triaminic Vapor Patch recall.

Reusable Ultrasound Transducer Assemblies
On June 19, 2006, the FDA issued a health notification regarding reusable ultrasound transducer assemblies used for various biopsy procedures. These instruments may not have been cleaned properly between uses. Learn more about biopsy procedures.

Recall of AED20 Automatic External Defibrillators
The Food and Drug Administration (FDA) has announced a June 15, 2006, recall of 580 AED20 automatic external defibrillators. According to the manufacturer, the recalled defibrillators may experience failure or unacceptable delay. Learn more about the recall of AED20 automatic external defibrillators.

Fusarium Keratitis Information
At the request of visitors to this site, we have gather information regarding Fusarium keratitis, the fungal eye infection linked to ReNu with MoistureLoc manufactured by Bausch & Lomb. Information includes an easy-to-understand definition, symptoms, treatment, and a brief explanation of possible product liability and medical malpractice cases. Learn more about Fusarium keratitis

Bausch & Lomb Recalls ReNu with MoistureLoc
May 15, 2006 – Almost exactly one month after withdrawing ReNu with MoistureLoc from the market, Bausch & Lomb officially recalls the product on a global basis. According to Bausch & Lomb, “unique characteristics of the formulation of the ReNu with MoistureLoc product in certain unusual circumstances can increase the risk of Fusarium infection.” Learn more about the recall of Bausch & Lomb ReNu with MoistureLoc.

Renu Recall
We are no longer taking cases related to fungal eye infection outbreak and ReNu with MoistureLoc and ReNu MultiPlus.

Recall of Blackstone Medical's ICON Modular Fixation System
In April of 2006, the Food and Drug Administration (FDA) announced a recall of Blackstone Medical’s ICON Modular Fixation System. The ICON Modular Fixation System is used for spinal surgery.According to the recall notification, The construct can loosen in the early postoperative period. This requires surgery to remove the ICON Modular Fixation System. There have been 484 surgical procedures in which the recalled devices have been implanted. Learn more about the recall of Blackstone Medical's ICON Modular Fixation System.

Illegally Harvested Human Tissue Used in Surgical Procedures around the Country
The FDA recalled human tissue, including bones, skin, and tendons used for implants, grafts, and transplants. According to the FDA the tissue was illegally harvested from cadavers at funeral homes in New York City, Rochester, Philadelphia, and New Jersey. 4 officers of Biomedical Tissue Services (BTS) have been charged with illeaglly harvesting the tissue. The tissue was not screened or tested for HIV, Hepatitis B or C, or syphilis. The BTS issue was processed and/or distributed by Regeneration Technologies, LifeCell Corporation, Tutogen Medical, Inc., Lost Mountain Tissue Bank, and Blood and Tissue Center of Central Texas. Medtronic, Inc., of Minneapolis, Minnesota, also used BTS tissue for bone graft products.

Mesh Recall
We are no longer taking cases related to this recall.

Free Case Consultation

We are Not Paid Unless You Win

Our attorneys work on a continguency fee basis, meaning you do not have to pay our law firm for representing you unless we win you money.

Firm News

AV Preeminent Rating by Martindale-Hubbell

Attorneys Fred Pritzker and Eric Hageman have been given the highest rating by Martindale-Hubbell for attorney, AV Preeminent. An AV® certification mark is a significant rating accomplishment - a testament to the fact that a lawyer's peers rank him or her at the highest level of professional excellence.

Adjunct Teaching Position At U of M Law School

Attorney Brendan Flaherty has accepted an adjunct teaching position at the University of Minnesota Law School. For the 2011 spring semester, Flaherty will teach a course entitled "Practice and Professionalism," which will introduce students to foundational lawyering skills and professional responsibility issues.

Attorney Elliot Olsen Speaks at Conference

Attorney Elliot Olsen recently spoke at the Seventh Annual LifeScience Alley Conference in Minneapolis on Preemption and the Future of Medical Device Litigation. He appeared with Randall Pattee of Lindquist and Vennum and Jean Lance, VP of corporate legal and general counsel for Boston Scientific.

Named Super Lawyer

In recognition of their achievements, Attorneys Fred Pritzker, Elliot Olsen and Eric Hageman were named "Super Lawyers" by Law & Politics magazine. According to Super Lawyers, "The objective is to create a credible, comprehensive and diverse listing of outstanding attorneys that can be used as a resource to assist attorneys and consumers in the search for legal counsel."

Brendan Flaherty Named a Rising Star

In recognition of his achievements, Attorney Brendan Flaherty was named a 2010 Rising Star by Minnesota Law & Politics. Only 2.5 percent of the state’s lawyers are included on the list, which highlights Minnesota’s best up-and-coming legal talent.

Fred Pritzker Listed in The Best Lawyers in America

Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.

This is attorney advertising. Past results do not guarantee a similar outcome. The result of each case is determined by the specific facts and the applicable law.